✦ LIBER ✦

Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study

✍ Scribed by C. Solaro; G. Brichetto; M. A. Battaglia; M. Messmer Uccelli; G. L. Mancardi

Publisher: Springer Milan
Year: 2005
Tongue: English
Weight: 44 KB
Volume: 25
Category: Article
ISSN: 1590-1874
DOI: 10.1007/s10072-004-0362-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sexual function in multiple sclerosis. A

Sexual function in multiple sclerosis. A 5-year follow-up study

✍ E. Stenager; E. N. Stenager; K. Jensen 📂 Article 📅 1996 🏛 Springer Milan 🌐 English ⚖ 361 KB

Acute and chronic pain syndromes in mult

Acute and chronic pain syndromes in multiple sclerosis. A 5-year follow-up study

✍ E. Stenager; L. Knudsen; K. Jensen 📂 Article 📅 1995 🏛 Springer Milan 🌐 English ⚖ 284 KB

Immunological effects of in vivo interfe

Immunological effects of in vivo interferon-β1btreatment in ten patients with multiple sclerosis: a 1-year follow-up

✍ M. Gelati; E. Corsini; A. Dufour; G. Massa; L. La Mantia; C. Milanese; A. Nespol 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 75 KB

Use of antipsychotic medications among e

Use of antipsychotic medications among elderly residents in long-term institutional care: a three-year follow-up

✍ Hanna-Mari Alanen; Harriet Finne-Soveri; Anja Noro; Esa Leinonen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## Objective To analyse the use of antipsychotic medications, change over time and associated factors in a three‐year follow‐up among elderly residents in long‐term institutional care. ## Design Retrospective study was designed with three identical cross‐sectional samples originating

Callosal tissue loss in multiple system

Callosal tissue loss in multiple system atrophy—A one-year follow-up study

✍ Martina Minnerop; Eileen Lüders; Karsten Specht; Jürgen Ruhlmann; Nicole Schimke 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

## Abstract Multiple system atrophy (MSA) is a neurodegenerative disease not only affecting the basal ganglia, brainstem, cerebellum, and intermediolateral cell columns of the spinal cord but also the cerebral cortex. Clinically, cerebellar (MSA‐C) and parkinsonian variants of MSA (MSA‐P) are disti

Azathioprine in multiple sclerosis—A 3 y

Azathioprine in multiple sclerosis—A 3 year controlled study of its effectiveness

✍ U. Patzold; P. Pocklington 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 895 KB

The results of a prospective, long-term controlled study on the treatment of multiple sclerosis with azathioprine are reported. The effect of a daily 2 mg/kg body weight dosage on 56 randomly chosen patients with multiple sclerosis is compared with a non-treated control group of 51 randomly selected